ROIV vs UTHR: stock comparison and AI forecast
Roivant Sciences Ltd. (ROIV) and United Therapeutics Corp (UTHR) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ROIV Roivant Sciences Ltd.
- Market Cap
- $27.61B
- P/E Ratio
- –
- Size
- large-cap
- AI Forecast
UTHR United Therapeutics Corp
- Market Cap
- $24.26B
- P/E Ratio
- 21.4x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ROIV is 1.1 times larger than UTHR by market capitalization ($27.61B against $24.26B).
- UTHR turns 38.6% of its revenue into net income, against -3535.0% for ROIV.
- UTHR carries 0.12 times debt per unit of equity, against 0.09 times for ROIV.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ROIV | UTHR |
|---|---|---|
| Market Cap | $27.61B | $24.26B |
| P/E Ratio | – | 21.38x |
| P/B Ratio | 6.53x | 3.87x |
| EPS | $-0.47 | $26.46 |
| Book Value/Share | $5.86 | $146.33 |
| Revenue/Share | $0.01 | $74.32 |
| FCF/Share | $-1.14 | $20.22 |
Profitability & Margins
| Metric | ROIV | UTHR |
|---|---|---|
| ROE | -6.3% | 19.6% |
| ROA | -5.0% | 17.5% |
| ROIC | -11.9% | 20.6% |
| Gross Margin | – | 86.3% |
| Operating Margin | -7914.8% | 41.5% |
| Net Margin | -3535.0% | 38.6% |
| EBT Margin | -3848.7% | 47.3% |
| Tax Rate | -43.0% | 18.4% |
Financial Health
| Metric | ROIV | UTHR |
|---|---|---|
| Current Ratio | 16.72x | 4.61x |
| Quick Ratio | – | 4.29x |
| D/E Ratio | 0.09x | 0.12x |
| Financial Leverage | 1.25x | 1.12x |
| Interest Coverage | 35.9x | 162.0x |
| Working Capital | $4.46B | $2.26B |
Cash Flow
| Metric | ROIV | UTHR |
|---|---|---|
| Operating Cash Flow | -$816M | $1.43B |
| Free Cash Flow | -$821M | $867M |
| Capital Spending | -$5M | -$562M |
| OCF Growth YoY | – | -8.1% |
| FCF Growth YoY | – | -22.7% |
| FCF/Sales | -10901.0% | 27.2% |
| CapEx/Sales | 61.0% | 17.6% |
Operational Efficiency
| Metric | ROIV | UTHR |
|---|---|---|
| Asset Turnover | 0.00x | 0.45x |
| Receivables Turnover | – | 9.1x |
| Inventory Turnover | – | 2.2x |
| Fixed Assets Turnover | 0.7x | 1.6x |
| Days Sales Outstanding | – | 40 days |
| Days Inventory | – | 169 days |
| Payables Period | – | 436 days |
| Cash Conversion Cycle | – | -227 days |
Income Statement
| Metric | ROIV | UTHR |
|---|---|---|
| Total Revenue | $8M | $3.19B |
| Operating Income | -$596M | $1.32B |
| Net Income | -$266M | $1.23B |
| R&D Expense | $731M | $703M |
| SG&A Expense | – | $728M |
| Cost of Goods Sold | – | $435M |
Dividend & Shareholder Information
| Metric | ROIV | UTHR |
|---|---|---|
| Shares Outstanding | 722M | 43M |
| Net Income Growth | – | -3.2% |
| EPS Growth | – | 0.1% |
ROIV vs UTHR: stock comparison and AI forecast
Which is bigger, ROIV or UTHR?
ROIV is 1.1 times larger than UTHR by market capitalization ($27.61B against $24.26B).
Which one does Intratio's AI model rank higher, ROIV or UTHR?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.